Wang Yundong, Han Zhen, Niu Xiaoping, Jia Yuliang, Yuan Heming, Zhang Guozheng, He Chiyi
Department of Gastroenterology, The Yijishan Hospital of Wannan Medical College Wuhu 241002, Anhui, People's Republic of China.
Int J Clin Exp Med. 2015 Apr 15;8(4):5753-9. eCollection 2015.
To analyze the effect of delayed hemorrhage after endoscopic sphincterotomy (EST) and compare the efficacy in improving complication between medicine treatment alone and medicine combined with endoscopic treatment. 1741 patients with EST admitted in Yijishan hospital of Wannan medical college from September 2009 to May 2014 were enrolled in this study. 32 cases suffered from delayed hemorrhage. The patients with delayed hemorrhage were evaluated through incision length of duodenal papilla, clinical manifestation, stool occult blood test and the difference of hemoglobin concentration between pre and post operation. 32 patients were divided into mild bleeding group, mild serious group and serious group through the speed and amount of bleeding. All cases in mild group accepted medicine treatment. Mild serious group were divided into medicine therapy group and medicine combined with endoscopic therapy group randomly. Serious group accepted vascular intervention therapy even traditional operation. The different treatments for delayed hemorrhage were judged by efficiency. The dates were analyzed by t-test or chi-square test. Nobody endured delayed hemorrhage who accepted small incision. Delayed hemorrhage was found in 7 patients out of 627 cases who accepted medium-large incision, 25 patients of 920 cases who accepted large incision. The patients who accepted lager EST were more dangerous than small EST (χ(2)=4.718, P=0.030) concerning delayed hemorrhage. 32 cases in 1741 patients suffered from delayed hemorrhage. 14 patients only have passed black stool after EST. Among 14 cases, 13 patients stop bleeding after medical therapy, and 1 case received endoscopic hemostasis. 15 cases with hematemesis or melena after EST, 7 patients who received combination therapy stop bleeding. 3 patients from 8 cases stop bleeding after single chemical treatment, 5 cases had to receive endoscopic hemostasis after ineffectual medical therapy. There are significant difference for concerning effect between combination therapy group and medical therapy group (P=0.026). 3 patients repeatedly vomited blood and develop to peripheral circulatory failure. Those patients all received vascular intervention therapy, 2 patients stop bleeding, 1 patient failed in vascular intervention therapy and given up emergency rescue and died. Large EST has more risks than small EST in concerning delayed hemorrhage. Delayed bleeding after EST should be treated by different levels. Adapted therapy should be recommend for patients with different levels bleeding.
分析内镜括约肌切开术(EST)后迟发性出血的影响,并比较单纯药物治疗与药物联合内镜治疗在改善并发症方面的疗效。选取2009年9月至2014年5月在皖南医学院弋矶山医院接受EST治疗的1741例患者纳入本研究。其中32例发生迟发性出血。通过十二指肠乳头切口长度、临床表现、大便潜血试验及手术前后血红蛋白浓度差异对迟发性出血患者进行评估。根据出血速度和出血量将32例患者分为轻度出血组、轻重度出血组和重度出血组。轻度组所有病例接受药物治疗。轻重度出血组随机分为药物治疗组和药物联合内镜治疗组。重度组接受血管介入治疗甚至传统手术。根据疗效判断迟发性出血的不同治疗方法。数据采用t检验或卡方检验进行分析。接受小切口手术的患者未发生迟发性出血。接受中 - 大切口手术的627例患者中有7例发生迟发性出血,接受大切口手术的920例患者中有25例发生迟发性出血。就迟发性出血而言,接受较大EST手术的患者比接受较小EST手术的患者更危险(χ(2)=4.718,P = 0.030)。1741例患者中有32例发生迟发性出血。14例患者EST术后仅出现黑便。在这14例患者中,13例经药物治疗后止血,1例接受内镜止血。15例患者EST术后出现呕血或黑便,7例接受联合治疗的患者止血。8例患者中有3例经单纯药物治疗后止血,5例药物治疗无效后不得不接受内镜止血。联合治疗组与药物治疗组在疗效方面存在显著差异(P = 0.026)。3例患者反复呕血并发展为外周循环衰竭。这些患者均接受血管介入治疗,2例患者止血,1例血管介入治疗失败后放弃抢救死亡。在迟发性出血方面,较大EST手术比小EST手术风险更高。EST术后迟发性出血应进行分级治疗。对于不同程度出血的患者应推荐适应性治疗。